Nephrology intervention to avoid acute kidney injury in patients awaiting cardiac surgery: randomized clinical trial

IntroductionCardiac surgery-associated acute kidney injury (CSA-AKI) is a well-known complication that increases morbidity and mortality rates. The objective of this study was to reduce CSA-AKI through nephrologist intervention in patients awaiting cardiac surgery.MethodsWe performed a single center...

Full description

Saved in:
Bibliographic Details
Main Authors: Sergi Codina, Laia Oliveras, Eva Ferreiro, Aroa Rovira, Ana Coloma, Nuria Lloberas, Edoardo Melilli, Miguel Hueso, Fabrizio Sbraga, Enric Boza, José M. Vazquez, José L. Pérez-Fernández, Joan Sabater, Josep M. Cruzado, Nuria Montero
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Nephrology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneph.2024.1470926/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846169099752701952
author Sergi Codina
Sergi Codina
Laia Oliveras
Laia Oliveras
Eva Ferreiro
Aroa Rovira
Ana Coloma
Nuria Lloberas
Edoardo Melilli
Miguel Hueso
Miguel Hueso
Fabrizio Sbraga
Enric Boza
José M. Vazquez
José L. Pérez-Fernández
Joan Sabater
Josep M. Cruzado
Josep M. Cruzado
Nuria Montero
Nuria Montero
author_facet Sergi Codina
Sergi Codina
Laia Oliveras
Laia Oliveras
Eva Ferreiro
Aroa Rovira
Ana Coloma
Nuria Lloberas
Edoardo Melilli
Miguel Hueso
Miguel Hueso
Fabrizio Sbraga
Enric Boza
José M. Vazquez
José L. Pérez-Fernández
Joan Sabater
Josep M. Cruzado
Josep M. Cruzado
Nuria Montero
Nuria Montero
author_sort Sergi Codina
collection DOAJ
description IntroductionCardiac surgery-associated acute kidney injury (CSA-AKI) is a well-known complication that increases morbidity and mortality rates. The objective of this study was to reduce CSA-AKI through nephrologist intervention in patients awaiting cardiac surgery.MethodsWe performed a single center, open-label, randomized clinical trial including 380 patients who underwent scheduled cardiac surgery at the Hospital de Bellvitge between July 2015 and October 2019. A total of 184 patients were evaluated by the same Nephrologist one month before the surgery to minimize the risk factors for AKI. In addition to assessments at the outpatient clinic, we also collected clinical data during hospitalization and during the first year.ResultsDespite the intervention, no differences were observed between the groups in the incidence of CSA-AKI (intervention group 26.37% vs. standard of care 25.13%, p=0.874), mortality (3.91% vs. 3.59%, p=0.999), length of Intensive Care Unit (ICU) stay (10 days [7.00;15.0] for both groups, p=0.347), or renal function after one year of follow-up (estimated glomerular filtration rate (eGFR) by CKD-EPI: 74.5 ml/min (standard deviation 20.6) vs 76.7 (20.8) ml/min, respectively, p=0.364). A reduction in the need for blood transfusion was observed in the intervention group, although the difference was not statistically significant (37.22% vs. 45.03%, p =0.155).ConclusionIn this clinical trial, nephrologist intervention in the entire population on the cardiac surgery waiting list did not show a nephroprotective benefit.Clinical trial registrationClinicalTrials.gov, identifier (NCT02643745).
format Article
id doaj-art-0d1aa2c25b4647edb4398e004048bea2
institution Kabale University
issn 2813-0626
language English
publishDate 2024-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nephrology
spelling doaj-art-0d1aa2c25b4647edb4398e004048bea22024-11-13T06:21:28ZengFrontiers Media S.A.Frontiers in Nephrology2813-06262024-11-01410.3389/fneph.2024.14709261470926Nephrology intervention to avoid acute kidney injury in patients awaiting cardiac surgery: randomized clinical trialSergi Codina0Sergi Codina1Laia Oliveras2Laia Oliveras3Eva Ferreiro4Aroa Rovira5Ana Coloma6Nuria Lloberas7Edoardo Melilli8Miguel Hueso9Miguel Hueso10Fabrizio Sbraga11Enric Boza12José M. Vazquez13José L. Pérez-Fernández14Joan Sabater15Josep M. Cruzado16Josep M. Cruzado17Nuria Montero18Nuria Montero19Nephrology, Hospital de Bellvitge, Barcelona, SpainNephrology, Idibell, Barcelona, SpainNephrology, Hospital de Bellvitge, Barcelona, SpainNephrology, Idibell, Barcelona, SpainNephrology, Hospital de Bellvitge, Barcelona, SpainNephrology, Hospital de Vinaros, Vinaros, SpainNephrology, Hospital de Bellvitge, Barcelona, SpainNephrology, Idibell, Barcelona, SpainNephrology, Hospital de Bellvitge, Barcelona, SpainNephrology, Hospital de Bellvitge, Barcelona, SpainNephrology, Idibell, Barcelona, SpainCardiac Surgery, Hospital de Bellvitge, Barcelona, SpainAnesthesiology, Hospital de Bellvitge, Barcelona, SpainAnesthesiology Department, Hospital Universitari de Vall Hebrón, Barcelona, SpainIntensive Care Unit, Hospital de Bellvitge, Barcelona, SpainIntensive Care Unit, Hospital de Bellvitge, Barcelona, SpainNephrology, Hospital de Bellvitge, Barcelona, SpainNephrology, Idibell, Barcelona, SpainNephrology, Hospital de Bellvitge, Barcelona, SpainNephrology, Idibell, Barcelona, SpainIntroductionCardiac surgery-associated acute kidney injury (CSA-AKI) is a well-known complication that increases morbidity and mortality rates. The objective of this study was to reduce CSA-AKI through nephrologist intervention in patients awaiting cardiac surgery.MethodsWe performed a single center, open-label, randomized clinical trial including 380 patients who underwent scheduled cardiac surgery at the Hospital de Bellvitge between July 2015 and October 2019. A total of 184 patients were evaluated by the same Nephrologist one month before the surgery to minimize the risk factors for AKI. In addition to assessments at the outpatient clinic, we also collected clinical data during hospitalization and during the first year.ResultsDespite the intervention, no differences were observed between the groups in the incidence of CSA-AKI (intervention group 26.37% vs. standard of care 25.13%, p=0.874), mortality (3.91% vs. 3.59%, p=0.999), length of Intensive Care Unit (ICU) stay (10 days [7.00;15.0] for both groups, p=0.347), or renal function after one year of follow-up (estimated glomerular filtration rate (eGFR) by CKD-EPI: 74.5 ml/min (standard deviation 20.6) vs 76.7 (20.8) ml/min, respectively, p=0.364). A reduction in the need for blood transfusion was observed in the intervention group, although the difference was not statistically significant (37.22% vs. 45.03%, p =0.155).ConclusionIn this clinical trial, nephrologist intervention in the entire population on the cardiac surgery waiting list did not show a nephroprotective benefit.Clinical trial registrationClinicalTrials.gov, identifier (NCT02643745).https://www.frontiersin.org/articles/10.3389/fneph.2024.1470926/fullacute kidney injurycardiac surgerynephrology interventionclinical trialsintensive care
spellingShingle Sergi Codina
Sergi Codina
Laia Oliveras
Laia Oliveras
Eva Ferreiro
Aroa Rovira
Ana Coloma
Nuria Lloberas
Edoardo Melilli
Miguel Hueso
Miguel Hueso
Fabrizio Sbraga
Enric Boza
José M. Vazquez
José L. Pérez-Fernández
Joan Sabater
Josep M. Cruzado
Josep M. Cruzado
Nuria Montero
Nuria Montero
Nephrology intervention to avoid acute kidney injury in patients awaiting cardiac surgery: randomized clinical trial
Frontiers in Nephrology
acute kidney injury
cardiac surgery
nephrology intervention
clinical trials
intensive care
title Nephrology intervention to avoid acute kidney injury in patients awaiting cardiac surgery: randomized clinical trial
title_full Nephrology intervention to avoid acute kidney injury in patients awaiting cardiac surgery: randomized clinical trial
title_fullStr Nephrology intervention to avoid acute kidney injury in patients awaiting cardiac surgery: randomized clinical trial
title_full_unstemmed Nephrology intervention to avoid acute kidney injury in patients awaiting cardiac surgery: randomized clinical trial
title_short Nephrology intervention to avoid acute kidney injury in patients awaiting cardiac surgery: randomized clinical trial
title_sort nephrology intervention to avoid acute kidney injury in patients awaiting cardiac surgery randomized clinical trial
topic acute kidney injury
cardiac surgery
nephrology intervention
clinical trials
intensive care
url https://www.frontiersin.org/articles/10.3389/fneph.2024.1470926/full
work_keys_str_mv AT sergicodina nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT sergicodina nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT laiaoliveras nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT laiaoliveras nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT evaferreiro nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT aroarovira nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT anacoloma nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT nurialloberas nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT edoardomelilli nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT miguelhueso nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT miguelhueso nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT fabriziosbraga nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT enricboza nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT josemvazquez nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT joselperezfernandez nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT joansabater nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT josepmcruzado nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT josepmcruzado nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT nuriamontero nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial
AT nuriamontero nephrologyinterventiontoavoidacutekidneyinjuryinpatientsawaitingcardiacsurgeryrandomizedclinicaltrial